Novel treatment of allergic diseases are of increasing importance. Dp1 and Dp2 receptor anagonists are an exciting prospect in this regard. Prevelance of allergic diseases is increasing worldwide especially in the developed world. The social and economic burden of allergic diseases is on the rise. Dp1 and Dp2 receptor antagonist provide a cost effective solution in the management of allergic diseases, especially the uncontrolled forms.